# TASK ORDER 7 - DOK7

> **NIH NIH N01** · A AND G PHARMACEUTICAL, INC. · 2024 · $105,670

## Abstract

Generation of purified polyclonal antibodies and monoclonal cell lines and purified monoclonal antibodies against DOK7

## Key facts

- **NIH application ID:** 11220353
- **Project number:** 271201800010I-0-759502400001-1
- **Recipient organization:** A AND G PHARMACEUTICAL, INC.
- **Principal Investigator:** AKIVA KOSOWSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $105,670
- **Award type:** —
- **Project period:** 2024-03-18 → 2025-03-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11220353

## Citation

> US National Institutes of Health, RePORTER application 11220353, TASK ORDER 7 - DOK7 (271201800010I-0-759502400001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11220353. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*